SECsense Logo

Biomea Fusion, Inc. 8-K Report: Key Updates & Insights for Investors

$BMEA
Form 8-K
Filed on: 2025-01-15
Source
Biomea Fusion, Inc. 8-K Report: Key Updates & Insights for Investors

From the provided section of the financial report, here are the key pieces of information and insights:

  1. Entity Information:
  • Company Name: Biomea Fusion, Inc.
  • CIK (Central Index Key): 0001840439
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-40335
  • EIN (Employer Identification Number): 82-2520134
  • Address: 900 Middlefield Road, 4th Floor, Redwood City, CA 94063
  • Contact Number: (650) 980-9099
  1. Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: January 13, 2025
  1. Securities Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001
  • Ticker Symbol: BMEA
  • Exchange: NASDAQ
  1. Time Context:
  • The report covers the date of January 13, 2025.

Insights:

  • The filing indicates a significant event or update from Biomea Fusion, Inc. on January 13, 2025, which is essential for investors and stakeholders.
  • Being listed on NASDAQ under the ticker symbol BMEA suggests that the company is publicly traded, which may indicate its size and the need for compliance with SEC regulations.
  • The par value of the common stock is relatively low, which may be common for many biotech companies at early stages or during specific financing strategies.

This information could be critical for investors looking to understand recent developments related to Biomea Fusion, Inc. and to assess its market position and compliance with regulatory requirements.